“…Associations between PvuII or XbaI polymorphisms and certain clinical conditions have been verified. These studies concern: risk of cardiovascular disease development (Herrington et al, 2002b;Myśliwska et al, 2009), osteoporosis (Albagha, McGuigan, Reid, & Ralstom, 2001;Becherini et al, 2009), cancer (Haiman et al, 1999;Weiderpass et al, 2000), increased blood pressure (Ellis, Infantino, & Harrap, 2004), spontaneous abortion (Anousha et al, 2013), multiple sclerosis (Niino, Kikuchi, Fukazawa, Yabe, & Tashiro, 2000), depression (Ryan & Ancelin, 2012), Alzheimer's disease (Boada et al, 2012), diabetes type 2 and obesity (Albagha et al, 2001), as well as type 1 diabetes (Ryba et al, 2011;Ryba-Stanisławowska, RybarczykKapturska, Brandt, Myśliwiec, & Myśliwska, 2014).…”